Opaleye Management Inc. Q3 2024 Filing
Filed November 14, 2024
Portfolio Value
$599.6B
Holdings
44
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (44 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HROWHARROW HEALTH INC | 3,990,000 | $179.4B | 29.92% | |
| 2 | TGTXTG THERAPEUTICS INC | 2,280,000 | $53.3B | 8.89% | |
| 3 | OCULOCULAR THERAPEUTIX INC | 5,025,000 | $43.7B | 7.29% | |
| 4 | ARVNARVINAS INC | 1,255,000 | $30.9B | 5.16% | |
| 5 | CDXSCODEXIS INC | 8,770,000 | $27.0B | 4.51% | |
| 6 | RYTMRHYTHM PHARMACEUTICALS INC | 500,000 | $26.2B | 4.37% | |
| 7 | KROSKEROS THERAPEUTICS INC | 395,276 | $23.0B | 3.83% | |
| 8 | IMNMIMMUNOME INC | 1,237,500 | $18.1B | 3.02% | |
| 9 | LQDALIQUIDIA CORPORATION | 1,698,142 | $17.0B | 2.83% | |
| 10 | ETONETON PHARMACEUTICALS INC | 2,780,000 | $16.7B | 2.78% | |
| 11 | EWTXEDGEWISE THERAPEUTICS INC | 522,500 | $13.9B | 2.33% | |
| 12 | CRGXCARGO THERAPEUTICS INC | 541,437 | $11.8B | 1.97% | |
| 13 | APLTAPPLIED THERAPEUTICS INC' | 1,320,000 | $11.2B | 1.87% | |
| 14 | PCVXVAXCYTE INC | 85,000 | $9.7B | 1.62% | |
| 15 | NRIXNURIX THERAPEUTICS INC | 420,000 | $9.4B | 1.57% | |
| 16 | SLRNACELYRIN INC | 1,893,660 | $9.3B | 1.56% | |
| 17 | TRVITREVI THERAPEUTICS INC | 2,567,990 | $8.6B | 1.43% | |
| 18 | BDSXBIODESIX INC | 3,815,000 | $7.0B | 1.16% | |
| 19 | DNAGINKGO BIOWORKS HOLDINGS | 820,202 | $6.7B | 1.11% | |
| 20 | JSPRJASPER THERAPEUTICS INC | 353,500 | $6.6B | 1.11% | |
| 21 | XOMAXOMA CORP DEL | 250,000 | $6.6B | 1.10% | |
| 22 | NUVLNUVALENT INC | 64,000 | $6.5B | 1.09% | |
| 23 | NAMSNEWAMSTERDAM PHARMA COMPANY | 335,000 | $5.6B | 0.93% | |
| 24 | URGNUROGEN PHARMA LTD | 404,100 | $5.1B | 0.86% | |
| 25 | PTGXPROTAGONIST THERAPEUTICS INC | 105,000 | $4.7B | 0.79% | |
| 26 | GOSS 5 06/01/27GOSSAMER BIO INC | 8,000,000 | $4.2B | 0.70% | |
| 27 | CYTKCYTOKINETICS INC | 75,300 | $4.0B | 0.66% | |
| 28 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 6,000,000 | $4.0B | 0.66% | |
| 29 | GOSSGOSSAMER BIO INC | 3,665,010 | $3.7B | 0.62% | |
| 30 | ZNTLZENTALIS PHARMACEUTICALS INC | 967,000 | $3.6B | 0.59% | |
| 31 | TARAPROTARA THERAPEUTICS INC | 1,681,154 | $3.1B | 0.51% | |
| 32 | RZLTREZOLUTE INC | 466,563 | $2.3B | 0.38% | |
| 33 | CPRXCATALYST PHARMACEUTICALS INC | 112,500 | $2.2B | 0.37% | |
| 34 | ABCLABCELLERA BIOLOGICS INC | 800,000 | $2.1B | 0.35% | |
| 35 | LYELLYELL IMMUNOPHARMA INC | 1,395,000 | $1.9B | 0.32% | |
| 36 | ALLKGUSDALLAKOS INC | 2,407,600 | $1.6B | 0.26% | |
| 37 | RLMDRELMADA THERAPEUTICS INC | 480,000 | $1.6B | 0.26% | |
| 38 | PEPGPEPGEN INC | 179,200 | $1.5B | 0.26% | |
| 39 | RVNCEURREVANCE THERAPEUTICS INC | 275,000 | $1.4B | 0.24% | |
| 40 | SYRSSYROS PHARMACEUTICALS INC | 654,943 | $1.4B | 0.23% | |
| 41 | AVTEAEROVATE THERAPEUTICS INC | 440,000 | $919.6M | 0.15% | |
| 42 | RGLSREGULUS THERAPEUTICS INC | 535,000 | $840.0M | 0.14% | |
| 43 | IBIOIBIO INC | 375,000 | $832.5M | 0.14% | |
| 44 | ADGMADAGIO MED HLDGS INC | 110,571 | $285.3M | 0.05% |